Scaled Biolabs has developed a new platform based on microfluidic technology spun-out of The University of Queensland's Australian Institute for Bioengineering and Nanotechnology that allows researchers to perform thousands of simultaneous cell culture experiments.
Scaled Biolabs is developing a Cell Therapy Discovery Engine to create cell-based medicines. This engine allows biotech and pharma companies to survey hundreds of parameters across tens of thousands of experimental processes. Scaled Biolabs also develops cell therapy assets internally, including a CIRM-funded program focusing on iPSC-derived dopaminergic neurons as a curative cell therapy for Parkinson's disease.
Celebrating Exciting CIRM-Funded Discovery Research on World Parkinson's Day
Karen Ring, CIRM
Micro experiments have huge cellular impact
Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform
Start-up makes quick work of cellular experiments
Documentaries, videos and podcasts
Scaled Biolabs Inc.
Drew Titmarsh, Ph.D.
San Francisco, CA
Cell Therapy Development Platform